Company: Calidi Biotherapeutics Inc.
Job title: President - Medical & Scientific Affairs
Allogeneic Stem Cell-Based Platforms to Potentiate & Deliver Oncolytic Virus Therapies 10:00 am
• Protecting oncolytic viruses from inactivation by complement, blocking antibodies and innate immune cells • Supporting oncolytic viral amplification inside the stem cells • Modifying tumor microenvironment by inducing transient immune modulation suppression to allow effective tumor cell targeting and viral amplification at the tumor sites for an extended periodRead more
day: Day Two